ambrisentan tablets

ambrisentan tablets
SPL v10
SPL
SPL Set ID 0e3e3320-27ac-404f-9f01-3d82696e768a
Route
oral
Published
Effective Date 2023-10-19
Document Type 34391-3 HUMAN PRESCRIPTION DRUG LABEL

Drug Facts

Composition & Product

Active Ingredients
ambrisentan (5 mg)
Inactive Ingredients
croscarmellose sodium lactose monohydrate lecithin, soybean magnesium stearate cellulose, microcrystalline polyethylene glycol, unspecified povidone talc titanium dioxide fd&c red no. 40 aluminum oxide polyvinyl alcohol, unspecified

Identifiers & Packaging

Pill Appearance
Imprint: 1180 Shape: round Shape: oval Color: pink Color: white Size: 8 mm Size: 10 mm Score: 1
Marketing Status
anda active Since 2019-04-12

Description

NDC 70771-1363-3 Ambrisentan Tablets, 5 mg 30 Tablets Rx only NDC 70771-1364-3 Ambrisentan Tablets, 10 mg 30 Tablets Rx only


Medication Information

Description

NDC 70771-1363-3 Ambrisentan Tablets, 5 mg 30 Tablets Rx only NDC 70771-1364-3 Ambrisentan Tablets, 10 mg 30 Tablets Rx only

Package Label.principal Display Panel

NDC 70771-1363-3

Ambrisentan Tablets, 5 mg

30 Tablets

Rx only

NDC 70771-1364-3

Ambrisentan Tablets, 10 mg

30 Tablets

Rx only


Structured Label Content

Package Label.principal Display Panel (PACKAGE LABEL.PRINCIPAL DISPLAY PANEL)

NDC 70771-1363-3

Ambrisentan Tablets, 5 mg

30 Tablets

Rx only

NDC 70771-1364-3

Ambrisentan Tablets, 10 mg

30 Tablets

Rx only


Advanced Ingredient Data


Raw Label Data

All Sections (JSON)